Executive Summary
Overnight filings reveal a mixed picture for US markets, with a notable cluster of insider selling at high-profile growth companies (Warby Parker, Airbnb, CrowdStrike) and a major deal collapse in the media sector (Shutterstock/Getty Images). The most significant positive signal is a broad-based equity grant program at General Mills, indicating strong long-term incentive alignment across its leadership team.
A key risk theme emerges from the pledging of a large block of Applied Digital shares against a margin loan, creating potential for forced selling. On the turnaround front, Huineng Technology reported a dramatic swing to profitability, while ENDRA Life Sciences regained Nasdaq compliance, removing a near-term delisting risk. The overall tone is cautious, with insider selling outweighing buying, but the General Mills grants and the Cellectar Biosciences option awards suggest confidence in future growth at specific companies.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4 · Schedule 13G · Schedule 13D · 8-K · 10-Q
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from July 08, 2026.
Investment Signals (10)
- Warby Parker ↓ (BEARISH)▲
Co-CEOs sold a combined ~$1.9M in stock at ~$29.90, with both executing via 10b5-1 plans. The CEO Gilboa's sale of 54,347 shares is the largest insider transaction in the filing set, signaling potential caution at current valuation levels
- Airbnb ↓ (BEARISH)▲
Chief Strategy Officer Blecharczyk sold $1.26M in stock at ~$148, a significant disposal by a key insider, suggesting limited upside conviction near current prices
- General Mills ↓ (BULLISH)▲
CEO and Chairman Harmening was awarded 69,214 shares and 346,069 options, while the CFO received 24,225 shares and 121,125 options. This massive, coordinated equity grant across 9 executives signals strong board confidence in the company's long-term strategy and alignment with shareholder value creation
- Cellectar Biosciences ↓ (BULLISH)▲
The CEO was awarded 250,000 stock options, and the COO 118,000, alongside grants to multiple directors. This aggressive option issuance suggests the board is incentivizing management for a significant stock price appreciation, likely tied to upcoming clinical milestones
- Shutterstock ↓ (BEARISH)▲
The termination of the Getty Images merger removes a significant overhang, but the failure to close after 18 months is a negative signal on strategic execution. The stock may face downward pressure as the 'deal premium' is removed
- Huineng Technology ↓ (BULLISH)▲
Revenue surged 509% YoY to $28,000, and the company swung from a net loss of -$21,036 to a net income of $10,067. This dramatic turnaround, driven by new service revenue and cost control, signals a potential inflection point for this micro-cap
- Essent Group ↓ (BEARISH)▲
Chairman, CEO & President Casale sold $1.92M in stock at $65.35, the largest single insider sale by value in the filing set. This is a notable disposal by the top executive of a mortgage insurer, potentially signaling a peak in the housing cycle
- GLAUKOS Corp ↓ (BEARISH)▲
The CFO sold $1.5M in stock at $150, while the Chief Development Officer sold a smaller amount. This is a significant insider sale by a top financial officer, warranting attention
- Cuentas Inc. ↓ (BULLISH)▲
CEO Maimon bought $1.13K worth of stock at $0.45. While small in absolute terms, this is the only insider purchase in the entire filing set, providing a contrarian bullish signal for a distressed micro-cap
- Annexon ↓ (BULLISH)▲
Redmile Group disclosed a 9.9% stake, with a new entity crossing the 5% threshold. This is a significant accumulation by a specialized healthcare investor, signaling confidence in the company's pipeline
Risk Flags (8)
- Applied Digital / Margin Loan Risk↓ [HIGH RISK]▼
Wesley Cummins pledged 17.6M shares (80% of his stake) as collateral for a margin loan with JPMorgan. A significant stock price decline could trigger a margin call, leading to forced selling that would pressure the stock further
- Warby Parker / Insider Selling Concentration↓ [HIGH RISK]▼
Both Co-CEOs sold stock on the same day, with combined proceeds of ~$1.9M. This coordinated selling by the top two executives is a strong negative signal about their near-term outlook
- Shutterstock / Failed Merger↓ [HIGH RISK]▼
The termination of the Getty Images merger after 18 months and a CMA condition to sell the editorial business represents a major strategic failure. The stock is likely to re-rate lower as the deal premium is removed and uncertainty about standalone strategy returns
- Huineng Technology / Going Concern Risk↓ [HIGH RISK]▼
Despite a profitable quarter, the company has negative working capital of -$10,662, cash of only $504, and an accumulated deficit of -$69,645. The business remains on a precarious financial footing
- MediaAlpha / Insider Selling Trend↓ [MEDIUM RISK]▼
Two insiders (a director and an officer) sold a combined ~$723K in stock at ~$14.00. This persistent selling at a relatively low stock price suggests a lack of confidence in a near-term recovery
- Maase Inc. / Major Shareholder Dumping↓ [HIGH RISK]▼
Baron Ren, a 19.1% owner, sold 8.2M shares for $12.3M on July 8, 2026. This massive one-day disposal by a top shareholder is a significant red flag and could signal deteriorating fundamentals or a loss of confidence
- ENDRA Life Sciences / Nasdaq Monitor Risk↓ [MEDIUM RISK]▼
While the company regained compliance, it is now subject to a one-year Discretionary Panel Monitor. Any further non-compliance will result in immediate delisting proceedings, creating a persistent overhang
- Lemonade / Insider Selling↓ [MEDIUM RISK]▼
The Chief Insurance Officer sold $272K in stock at $79.00. While not a massive sale, it is a disposal by a key operational executive in a company that is still not profitable
Opportunities (8)
- General Mills / Long-Term Incentive Alignment↓ (OPPORTUNITY)◆
The massive equity grants to 9 top executives, including the CEO and CFO, create a powerful alignment with shareholders. The 5-year vesting periods (implied) suggest management is focused on long-term value creation, making the stock attractive for patient investors
- Cellectar Biosciences / Option-Led Incentive↓ (OPPORTUNITY)◆
The CEO's 250,000 option grant at a likely near-market strike price is a strong signal that the board expects significant stock appreciation. This is a classic catalyst for a biotech with upcoming data readouts
- Huineng Technology / Turnaround Play↓ (OPPORTUNITY)◆
The 509% YoY revenue growth and swing to profitability, combined with a tiny market cap, presents a high-risk, high-reward turnaround opportunity. The company is generating positive operating cash flow for the first time
- Annexon / Activist/Investor Catalyst↓ (OPPORTUNITY)◆
Redmile Group's increased stake to 9.9% and the new 5% holder suggest growing institutional interest. This could lead to strategic changes or a sale process, creating upside
- Cuentas Inc. / Contrarian Insider Buy↓ (OPPORTUNITY)◆
The CEO's purchase at $0.45, while small, is the only insider buy in the entire filing set. In a sea of selling, this lone vote of confidence from the CEO could signal a bottom for this distressed stock
- ENDRA Life Sciences / Delisting Risk Removed↓ (OPPORTUNITY)◆
The company has regained Nasdaq compliance, removing a major overhang. The stock could re-rate as the risk of a catastrophic delisting event is eliminated
- KB Financial Group / Earnings Catalyst↓ (OPPORTUNITY)◆
The company has scheduled its 1H 2026 earnings call for July 23. With Korean banks benefiting from higher interest rates, the results could provide a positive catalyst for the ADR
- Equinox Gold / Potential Catalyst↓ (OPPORTUNITY)◆
While the filing was procedural, Equinox Gold is a producing gold miner. With gold prices remaining elevated, any operational update or production guidance in upcoming filings could be a positive catalyst
Sector Themes (5)
- Insider Selling Dominates Growth Stocks◆
A clear pattern of insider selling at high-growth, often unprofitable companies (Warby Parker, Airbnb, Lemonade, Rivian) suggests that management teams are taking profits or hedging against downside risk. This is a cautious signal for the broader growth stock rally.
- Consumer Discretionary Caution◆
Insider selling at Warby Parker (eyewear) and Airbnb (travel) points to potential headwinds in consumer spending. The $1.9M combined sale by Warby Parker's co-CEOs is particularly notable and suggests a peak in consumer demand for discretionary items.
- Biotech Insider Optimism◆
In contrast to the broader market, insider activity in biotech is bullish. Cellectar Biosciences issued massive option grants to its CEO and COO, and Annexon saw a major investor increase its stake. This suggests confidence in upcoming clinical catalysts and pipeline value.
- Failed M&A Creates Risk and Opportunity◆
The Shutterstock/Getty Images deal collapse is a clear negative for Shutterstock, removing a premium and creating strategic uncertainty. However, it also removes a regulatory overhang and could make Shutterstock a more attractive standalone or acquisition target.
- Margin Loan Pledging as a Systemic Risk◆
The Applied Digital filing highlights a growing risk in the market: insiders pledging large blocks of stock as collateral for loans. A sharp market downturn could trigger a cascade of forced selling, amplifying downside moves in these names.
Watch List (8)
-
Watch for any further disclosure on the JPMorgan margin loan. A significant drop in the stock price could trigger a margin call, leading to forced selling of 17.6M shares. Monitor the stock price closely.
-
Following the Getty Images deal collapse, watch for any announcement of a new strategic plan, share buyback, or potential new acquirer. The stock is likely to be volatile.
-
Monitor for any further insider sales by the co-CEOs or other top executives. A continuation of the selling pattern would be a strong negative signal.
-
With only $504 in cash, the company needs to raise capital or generate significant cash flow. Watch for a dilutive financing announcement or a further deterioration in the cash position.
-
The massive option grants suggest an upcoming catalyst. Watch for clinical trial data readouts or regulatory updates that could drive the stock price significantly higher.
-
The 1H 2026 earnings call is a key catalyst. Watch for net interest margin trends, loan growth, and shareholder return announcements.
-
After Baron Ren's massive $12.3M sale, watch for any further disposals. Continued selling by this top shareholder would be a major red flag.
-
The large equity grants suggest management is confident in the outlook. Watch for the next earnings report for potential upside surprises driven by cost savings or volume growth.
Filing Analyses
(50)
08-07-2026
CHIEF DEVELOPMENT OFFICER Navratil Tomas sold 716 Common Stock at $139.06 (~$99.6K). Navratil Tomas holds 87,634 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CHIEF DEVELOPMENT OFFICER Navratil Tomas sold 716 Common Stock at $139.06 (~$99.6K)
08-07-2026
Director Boone Karen sold 20,000 Class A Common Stock at $20.00 (~$400K). Boone Karen holds 110,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Boone Karen sold 20,000 Class A Common Stock at $20.00 (~$400K)
08-07-2026
Director THAMAN MICHAEL H was awarded 340 Deferred Stock Units.
- · Director THAMAN MICHAEL H was awarded 340 Deferred Stock Units
08-07-2026
Director Kini Vikram was awarded 213 Deferred Stock Units.
- · Director Kini Vikram was awarded 213 Deferred Stock Units
08-07-2026
Director Chanan-Khan Asher was awarded 25,000 Stock option (right to buy).
- · Director Chanan-Khan Asher was awarded 25,000 Stock option (right to buy)
08-07-2026
President & CEO CARUSO JAMES V was awarded 250,000 Stock option (right to buy).
- · President & CEO CARUSO JAMES V was awarded 250,000 Stock option (right to buy)
08-07-2026
Director Gu Andrew was awarded 25,000 Stock option (right to buy).
- · Director Gu Andrew was awarded 25,000 Stock option (right to buy)
08-07-2026
Chief Operating Officer Longcor Jarrod was awarded 118,000 Stock option (right to buy).
- · Chief Operating Officer Longcor Jarrod was awarded 118,000 Stock option (right to buy)
08-07-2026
EXECUTIVE CHAIRMAN Rabinowitz Matthew sold 1,000 Common Stock at $280.00 (~$280K). Rabinowitz Matthew holds 4,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · EXECUTIVE CHAIRMAN Rabinowitz Matthew sold 1,000 Common Stock at $280.00 (~$280K)
08-07-2026
Director Swirsky Douglas J was awarded 37,500 Stock option (right to buy).
- · Director Swirsky Douglas J was awarded 37,500 Stock option (right to buy)
08-07-2026
10% owner OREGON COMMUNITY FOUNDATION sold 18,267 Common Stock at $2.50 (~$45.8K). OREGON COMMUNITY FOUNDATION holds 743,816 shares after the transaction.
- · 10% owner OREGON COMMUNITY FOUNDATION sold 18,267 Common Stock at $2.50 (~$45.8K)
- · 10% owner OREGON COMMUNITY FOUNDATION sold 1,451 Common Stock at $2.51 (~$3.64K)
08-07-2026
Director NEIS JOHN was awarded 25,000 Stock option (right to buy).
- · Director NEIS JOHN was awarded 25,000 Stock option (right to buy)
08-07-2026
Loren Stefan was awarded 15,000 Stock option (right to buy).
- · Loren Stefan was awarded 15,000 Stock option (right to buy)
08-07-2026
Director OLEARY DENIS gifted 49,500 Class A common stock. OLEARY DENIS holds 49,500 shares after the transaction.
- · Director OLEARY DENIS gifted 49,500 Class A common stock
- · Director OLEARY DENIS gifted 49,500 Class A common stock
08-07-2026
Co-Chief Executive Officer Blumenthal Neil Harris sold 9,200 Class A Common Stock at $29.99 (~$276K). Blumenthal Neil Harris holds 31,112 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Co-Chief Executive Officer Blumenthal Neil Harris exercised/converted 9,200 Class A Common Stock
- · Co-Chief Executive Officer Blumenthal Neil Harris sold 9,200 Class A Common Stock at $29.99 (~$276K)
- · Co-Chief Executive Officer Blumenthal Neil Harris exercised/converted 9,200 Class B Common Stock
08-07-2026
Chief Financial Officer Williamson Andrew was awarded 2,539 Common Shares. Williamson Andrew holds 199,276 shares after the transaction.
- · Chief Financial Officer Williamson Andrew was awarded 2,539 Common Shares
- · Chief Financial Officer Williamson Andrew was awarded 7,803 Common Shares
08-07-2026
Co-Chief Executive Officer Gilboa David Abraham sold 54,347 Class A Common Stock at $29.84 (~$1.62M). 5 transactions reported in total. Gilboa David Abraham holds 31,112 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Co-Chief Executive Officer Gilboa David Abraham exercised/converted 54,347 Class A Common Stock
- · Co-Chief Executive Officer Gilboa David Abraham sold 54,347 Class A Common Stock at $29.84 (~$1.62M)
- · Co-Chief Executive Officer Gilboa David Abraham exercised/converted 54,347 Stock Option (Right to Buy)
- · Co-Chief Executive Officer Gilboa David Abraham exercised/converted 54,347 Class B Common Stock at $3.83 (~$208K)
- · Co-Chief Executive Officer Gilboa David Abraham exercised/converted 54,347 Class B Common Stock
08-07-2026
CFO Kolean Chad J was awarded 92,000 Stock option (right to buy).
- · CFO Kolean Chad J was awarded 92,000 Stock option (right to buy)
08-07-2026
SVP & CHIEF FINANCIAL OFFICER Thurman Alex R. sold 10,000 Common Stock at $150.00 (~$1.5M). Thurman Alex R. holds 43,681 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · SVP & CHIEF FINANCIAL OFFICER Thurman Alex R. exercised/converted 10,000 Common Stock at $38.68 (~$387K)
- · SVP & CHIEF FINANCIAL OFFICER Thurman Alex R. sold 10,000 Common Stock at $150.00 (~$1.5M)
- · SVP & CHIEF FINANCIAL OFFICER Thurman Alex R. exercised/converted 10,000 Stock Option (Right to Buy) at $38.68 (~$387K)
08-07-2026
Director DRISCOLL FREDERICK W was awarded 25,000 Stock option (right to buy).
- · Director DRISCOLL FREDERICK W was awarded 25,000 Stock option (right to buy)
08-07-2026
Chairman, CEO and President CASALE MARK sold 29,329 Common shares, par value $0.015 at $65.35 (~$1.92M). CASALE MARK holds 2,184,143 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chairman, CEO and President CASALE MARK sold 1,245 Common shares, par value $0.015 at $65.08 (~$81K)
- · Chairman, CEO and President CASALE MARK sold 29,329 Common shares, par value $0.015 at $65.35 (~$1.92M)
08-07-2026
Chief Executive Officer Stabell Jason was awarded 6,094 Common Shares. Stabell Jason holds 549,682 shares after the transaction.
- · Chief Executive Officer Stabell Jason was awarded 6,094 Common Shares
- · Chief Executive Officer Stabell Jason was awarded 18,726 Common Shares
08-07-2026
Redmile Group, LLC and related entities filed an amended Schedule 13G disclosing beneficial ownership of 17,918,459 shares (9.9%) of Annexon, Inc. common stock as of July 8, 2026. The filing also reports that RedCo II Offshore SPV LLC has crossed the 5% threshold, owning 9,802,458 shares (5.5%). The ownership includes shares and pre-funded warrants subject to a 9.99% beneficial ownership limitation.
- · This is Amendment No. 6 to the Schedule 13G, adding RedCo II Offshore SPV LLC as a reporting person after it crossed the 5% ownership threshold on July 1, 2026.
- · The beneficial ownership includes 14,548,896 shares of common stock and 3,369,563 shares issuable upon exercise of pre-funded warrants, all subject to a 9.99% beneficial ownership limitation.
- · Redmile Group, LLC serves as investment manager for the Redmile Funds, which directly hold the securities.
- · Jeremy C. Green is the principal of Redmile and may be deemed to beneficially own the securities.
- · The filing certifies that the securities were not acquired to change or influence control of Annexon.
08-07-2026
Chief Strategy Officer Blecharczyk Nathan sold 8,487 Class A Common Stock at $148.36 (~$1.26M). Blecharczyk Nathan holds 81,677 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Strategy Officer Blecharczyk Nathan sold 3,104 Class A Common Stock at $147.86 (~$459K)
- · Chief Strategy Officer Blecharczyk Nathan sold 8,487 Class A Common Stock at $148.36 (~$1.26M)
- · Chief Strategy Officer Blecharczyk Nathan sold 2,024 Class A Common Stock at $149.24 (~$302K)
08-07-2026
See Remarks Yi Steven sold 26,467 Class A Common Stock at $14.07 (~$372K). Yi Steven holds 2,715,969 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · See Remarks Yi Steven sold 17,254 Class A Common Stock at $14.01 (~$242K)
- · See Remarks Yi Steven sold 26,467 Class A Common Stock at $14.07 (~$372K)
08-07-2026
Director Nonko Eugene sold 25,352 Class A Common Stock at $13.86 (~$351K). 6 transactions reported in total. Nonko Eugene holds 1,119,575 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Nonko Eugene sold 24,992 Class A Common Stock at $13.91 (~$348K)
- · Director Nonko Eugene sold 4,952 Class A Common Stock at $14.08 (~$69.7K)
- · Director Nonko Eugene sold 3,282 Class A Common Stock at $13.78 (~$45.2K)
- · Director Nonko Eugene sold 25,352 Class A Common Stock at $13.86 (~$351K)
- · Director Nonko Eugene sold 9,524 Class A Common Stock at $14.06 (~$134K)
- · Director Nonko Eugene sold 8,205 Class A Common Stock at $13.61 (~$112K)
08-07-2026
Wesley Cummins filed a Schedule 13D/A disclosing beneficial ownership of 22,042,487 shares (7.6%) of Applied Digital Corp. as of July 7, 2026. The filing also reveals that Cummins Family Limited Partnership entered into a secured margin line of credit agreement with JPMorgan Chase Bank, N.A., pledging 17,590,238 shares as collateral. While the filing shows continued insider ownership, the pledging of a substantial portion of shares introduces potential downside risk if margin calls occur.
- · The margin loan agreement with JPMorgan allows the lender to foreclose on pledged shares upon collateral shortfall or default, which could lead to forced selling.
- · Wesley Cummins received 800,000 shares upon vesting of PSUs on June 22, 2026, but 314,800 shares were withheld for taxes.
- · Unvested RSUs from January 2026 grants are not included in beneficial ownership as they will not vest within 60 days.
- · The margin line of credit has no commitment from JPMorgan to lend; each loan is at the bank's sole discretion.
08-07-2026
Chief Accounting Officer Pallot Mark A was awarded 2,077 Common Stock. Pallot Mark A holds 20,446.462 shares after the transaction.
- · Chief Accounting Officer Pallot Mark A was awarded 2,077 Common Stock
- · Chief Accounting Officer Pallot Mark A was awarded 10,383 Non-Qualified Stock Option (right to buy)
08-07-2026
Chief S&G Officer Saksena Asheesh was awarded 13,063 Common Stock. Saksena Asheesh holds 26,009 shares after the transaction.
- · Chief S&G Officer Saksena Asheesh was awarded 13,063 Common Stock
- · Chief S&G Officer Saksena Asheesh was awarded 58,832 Non-Qualified Stock Option (right to buy)
08-07-2026
Chief Innovation Officer Shaffer Werner Lanette was awarded 6,576 Common Stock. Shaffer Werner Lanette holds 38,042.9867 shares after the transaction.
- · Chief Innovation Officer Shaffer Werner Lanette was awarded 6,576 Common Stock
- · Chief Innovation Officer Shaffer Werner Lanette was awarded 32,877 Non-Qualified Stock Option (right to buy)
08-07-2026
Segment President Sharma Pankaj MN was awarded 6,576 Common Stock. Sharma Pankaj MN holds 47,045.058 shares after the transaction.
- · Segment President Sharma Pankaj MN was awarded 6,576 Common Stock
- · Segment President Sharma Pankaj MN was awarded 32,877 Non-Qualified Stock Option (right to buy)
08-07-2026
General Counsel & Secretary THISSEN KAREN WILSON was awarded 11,767 Common Stock. THISSEN KAREN WILSON holds 95,494.065 shares after the transaction.
- · General Counsel & Secretary THISSEN KAREN WILSON was awarded 11,767 Common Stock
- · General Counsel & Secretary THISSEN KAREN WILSON was awarded 58,832 Non-Qualified Stock Option (right to buy)
08-07-2026
Director Glajch Jeffrey sold 14,295 Class A Common Stock at $13.60 (~$194K). Glajch Jeffrey holds 340,321 shares after the transaction.
- · Director Glajch Jeffrey sold 14,295 Class A Common Stock at $13.60 (~$194K)
- · Director Glajch Jeffrey sold 7,485 Class A Common Stock at $12.97 (~$97.1K)
08-07-2026
Chief Human Resources Officer Williams-Roll Jacqueline was awarded 8,998 Common Stock. Williams-Roll Jacqueline holds 68,292.1759 shares after the transaction.
- · Chief Human Resources Officer Williams-Roll Jacqueline was awarded 8,998 Common Stock
- · Chief Human Resources Officer Williams-Roll Jacqueline was awarded 44,989 Non-Qualified Stock Option (right to buy)
08-07-2026
Segment President Fernandez Ricardo was awarded 6,576 Common Stock. Fernandez Ricardo holds 82,599.613 shares after the transaction.
- · Segment President Fernandez Ricardo was awarded 6,576 Common Stock
- · Segment President Fernandez Ricardo was awarded 32,877 Non-Qualified Stock Option (right to buy)
08-07-2026
CEO Maimon Shalom Arik bought 2,500 Common Stock at $0.45 (~$1.13K). Maimon Shalom Arik holds 870,563 shares after the transaction.
- · CEO Maimon Shalom Arik bought 2,500 Common Stock at $0.45 (~$1.13K)
08-07-2026
Chief Insurance Officer Peters John Sheldon sold 3,444 COMMON STOCK at $79.00 (~$272K). Peters John Sheldon holds 77,942 shares after the transaction.
- · Chief Insurance Officer Peters John Sheldon sold 3,444 COMMON STOCK at $79.00 (~$272K)
08-07-2026
Chief Financial Officer Bruce Kofi A was awarded 24,225 Common Stock. Bruce Kofi A holds 257,316.1867 shares after the transaction.
- · Chief Financial Officer Bruce Kofi A was awarded 24,225 Common Stock
- · Chief Financial Officer Bruce Kofi A was awarded 121,125 Non-Qualified Stock Option (right to buy)
08-07-2026
Chairman of the Board & CEO HARMENING JEFFREY L was awarded 69,214 Common Stock. HARMENING JEFFREY L holds 454,169.3201 shares after the transaction.
- · Chairman of the Board & CEO HARMENING JEFFREY L was awarded 69,214 Common Stock
- · Chairman of the Board & CEO HARMENING JEFFREY L was awarded 346,069 Non-Qualified Stock Option (right to buy)
08-07-2026
Segment President Mascolo Elizabeth was awarded 6,576 Common Stock. Mascolo Elizabeth holds 41,428.287 shares after the transaction.
- · Segment President Mascolo Elizabeth was awarded 6,576 Common Stock
- · Segment President Mascolo Elizabeth was awarded 32,877 Non-Qualified Stock Option (right to buy)
08-07-2026
Chief Operating Officer McNabb Dana M was awarded 27,686 Common Stock. McNabb Dana M holds 92,881.454 shares after the transaction.
- · Chief Operating Officer McNabb Dana M was awarded 27,686 Common Stock
- · Chief Operating Officer McNabb Dana M was awarded 138,428 Non-Qualified Stock Option (right to buy)
08-07-2026
Chief Technology Officer Montemayor Jaime was awarded 17,304 Common Stock. Montemayor Jaime holds 179,672.029 shares after the transaction.
- · Chief Technology Officer Montemayor Jaime was awarded 17,304 Common Stock
- · Chief Technology Officer Montemayor Jaime was awarded 86,518 Non-Qualified Stock Option (right to buy)
08-07-2026
Chief Supply Chain Officer Ness Jonathan David was awarded 5,884 Common Stock. Ness Jonathan David holds 20,498 shares after the transaction.
- · Chief Supply Chain Officer Ness Jonathan David was awarded 5,884 Common Stock
- · Chief Supply Chain Officer Ness Jonathan David was awarded 29,416 Non-Qualified Stock Option (right to buy)
09-07-2026
ENDRA Life Sciences Inc. received a notice from Nasdaq on July 8, 2026, confirming it has regained compliance with the Minimum Stockholders' Equity Requirement of $2,500,000, following a hearing on May 28, 2026. However, the company will be subject to a Discretionary Panel Monitor for one year, during which any further non-compliance could lead to immediate delisting proceedings without the usual cure periods.
- · The company was initially notified of non-compliance on April 20, 2026, based on its 2025 Annual Report.
- · A hearing before the Nasdaq Hearing Panel was held on May 28, 2026.
- · The monitoring period runs for one year from July 1, 2026.
- · If non-compliance occurs during monitoring, the company cannot submit a plan of compliance and will receive a Delist Determination Letter, though it may request a new hearing.
09-07-2026
Baron Ren, through his wholly-owned entity Golden Brighter Limited, filed an amended Schedule 13D disclosing a 19.10% beneficial ownership stake in Maase Inc. as of July 8, 2026. The filing reveals two recent disposals: 380,000 Class A shares on January 15, 2026 for $570,000, and 8,197,938 Class A shares on July 8, 2026 for $12,296,907. Despite these sales, the ownership percentage remained high at 19.10%, though voting power is only 7.66% due to the superior voting rights of Class B shares.
- · The filing is Amendment No. 3 to Schedule 13D, originally filed September 5, 2025.
- · Golden Brighter Limited is 100% owned by Baron Ren.
- · Each Class A share has 1 vote; each Class B share has 100 votes.
- · The disposals were in privately negotiated transactions, not open market sales.
- · No other person has the right to receive dividends or proceeds from the shares.
09-07-2026
KB Financial Group Inc. announced its 2026 First Half Earnings Conference will be held on Thursday, July 23, 2026, via live webcast and conference call. The event will cover first half earnings results and include a Q&A session. No financial results or performance data were disclosed in this filing.
- · Earnings conference scheduled for July 23, 2026 at 16:00 Korea time.
- · Simultaneous English interpretation will be available.
- · Dial-in details for Q&A: from overseas 82-31-810-3128, from Korea 031-810-3128, passcode 6412#.
- · Presentation materials will be available on the IR website at www.kbfg.com.
09-07-2026
Huineng Technology Corp (HNIT) reported a dramatic turnaround for the six months ended May 31, 2026, with revenue surging to $28,000 from $4,600 in the prior-year period, driven by new development service revenue of $12,000 and a sharp increase in design service revenue to $15,000. The company swung to a net income of $10,067 from a net loss of ($21,036) in the prior period, largely due to a significant reduction in general and administrative expenses. However, cash and cash equivalents declined to $504 from $758 at the start of the period, and the company continues to operate with negative working capital and an accumulated deficit of ($69,645).
- · The company had negative working capital of $10,662 in current liabilities vs $13,487 in current assets as of May 31, 2026.
- · Cash used in operating activities was ($254) for the six months ended May 31, 2026, compared to ($1,584) in the prior period.
- · Accounts receivable increased from $0 to $5,000 during the six-month period.
- · The company had no income tax expense for any period reported.
- · Net income per share (basic and diluted) was $0.0002 for the six months ended May 31, 2026, compared to a loss of ($0.0008) per share in the prior period.
- · The weighted average number of shares outstanding increased to 44,545,000 for the six months ended May 31, 2026 from 26,856,475 in the prior period.
09-07-2026
Noah Holdings Ltd filed a Form 6-K with the SEC on July 9, 2026, attaching a next day disclosure return and a monthly return on movements in securities for its equity issuer and Hong Kong depositary receipts listed under Chapter 19B of the Exchange Listing Rules. The filing is procedural in nature and does not contain any financial results, business performance data, or material corporate events.
09-07-2026
Equinox Gold Corp. filed a Form 6-K with the SEC on July 9, 2026, attaching a press release dated the same day. The filing is a routine foreign issuer report under Rule 13a-16 or 15d-16, with no specific financial results or material events disclosed in the cover page.
- · Filing is a Form 6-K for the month of July 2026.
- · Commission File Number: 001-39038.
- · Address: 700 West Pender Street, Suite 1501, Vancouver, British Columbia, V6C 1G8.
- · Registrant files annual reports under Form 40-F.
- · Exhibit 99.1 is a press release dated July 9, 2026.
09-07-2026
Shutterstock, Inc. announced the termination of its merger agreement with Getty Images Holdings, Inc., originally entered into on January 6, 2025. The termination followed the U.K. Competition and Markets Authority's conditional clearance requiring the sale of Shutterstock's editorial business, which Getty Images' board decided not to pursue. The merger agreement was terminated on July 7, 2026, after the Second Extended End Date passed.
- · The merger agreement was originally entered into on January 6, 2025.
- · The CMA conditioned clearance on the sale of Shutterstock's editorial business.
- · Getty Images' board unanimously resolved not to proceed with the editorial business sale process.
- · The termination occurred after the Second Extended End Date (July 6, 2026) passed.
- · The termination was effective July 7, 2026.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Pre-Market SEC Filings Roundup
🇺🇸 More from United States
View all →July 09, 2026
Nasdaq 100 Stocks SEC Filings — July 09, 2026
Nasdaq 100 Stocks SEC Filings
July 09, 2026
Global High-Priority Regulatory Events — July 09, 2026
Global High-Priority Regulatory Events
July 09, 2026
US SEC Filings Daily Market Digest — July 09, 2026
US SEC Filings Daily Market Digest
July 09, 2026
S&P 500 Consumer Discretionary Sector SEC Filings — July 09, 2026
S&P 500 Consumer Discretionary Sector SEC Filings